Elanco Animal Health Inc
Closed
SectorHealthcare
23.29 -3.8
Overview
Share price change
24h
Min
23.11
Max
24.41
Income | 289M 57M |
|---|---|
Sales | 227M 1.4B |
P/E Sector Avg | 372.714 49.712 |
EPS | 0.4 |
Profit margin | 4.158 |
Employees | 9,400 |
EBITDA | 138M 144M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +20.21% upside |
Next Earnings | 6 Aug 2026 |
|---|
Market Cap | 891M 12B |
|---|---|
Previous open | 27.09 |
Previous close | 23.29 |
Elanco Animal Health Inc Chart
Past performance is not a reliable indicator of future results.
About Elanco Animal Health Inc
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.